Literature DB >> 15824876

[Peculiarities in the follow up of resynchronization therapy].

G Fröhlig1.   

Abstract

While resynchronization therapy (CRT) is based on conventional pacemaker- and ICD technology, its main intention is to minimize inter- and intraventricular asynergy and to establish optimal AV timing if sinus rhythm is preserved. The focus of this contribution is a series of conditions which jeopardize the therapeutic goal of CRT and should be recognized and hopefully corrected during follow up of CRT systems. These scenarios include uncertainties about left ventricular capture, double sensing in the ventricles, inhibition of the ventricular output (and loss of resynchronization), atrial and ventricular tachycardia and rate adaptation. Technical issues of following rhythm management devices are only discussed in the context of CRT requirements.

Entities:  

Mesh:

Year:  2005        PMID: 15824876     DOI: 10.1007/s00399-005-0451-3

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  21 in total

1.  Echocardiographic modeling of cardiac dyssynchrony before and during multisite stimulation: a prospective study.

Authors:  S Cazeau; P Bordachar; G Jauvert; A Lazarus; C Alonso; M C Vandrell; J Mugica; P Ritter
Journal:  Pacing Clin Electrophysiol       Date:  2003-01       Impact factor: 1.976

2.  Anodal capture with second-generation biventricular cardioverter-defibrillator.

Authors:  Bengt Herweg; S Serge Barold
Journal:  Acta Cardiol       Date:  2003-10       Impact factor: 1.718

3.  Double counting of the ventricular electrogram in biventricular pacemakers and ICDs.

Authors:  S Serge Barold; Bengt Herweg; Ignacio Gallardo
Journal:  Pacing Clin Electrophysiol       Date:  2003-08       Impact factor: 1.976

4.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

5.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

6.  A new and reliable method of individual ventricular capture identification during biventricular pacing threshold testing.

Authors:  P Yong; C Duby
Journal:  Pacing Clin Electrophysiol       Date:  2000-11       Impact factor: 1.976

7.  Matching approved "nondedicated" hardware to obtain biventricular pacing and defibrillation: feasibility and troubleshooting.

Authors:  Logan Kanagaratnam; Stephen Pavia; Robert Schweikert; Nassir Marrouche; Cathy Lam; Miguel Abreu; Elizabeth Ching; Mina Chung; Walid Saliba; Mark Niebauer; Bruce Wilkoff; Patrick Tchou; Andrea Natale
Journal:  Pacing Clin Electrophysiol       Date:  2002-07       Impact factor: 1.976

8.  Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation.

Authors:  Valérie Valls-Bertault; Marjaneh Fatemi; Martine Gilard; Pierre Yves Pennec; Yves Etienne; Jean-Jacques Blanc
Journal:  Europace       Date:  2004-09       Impact factor: 5.214

9.  Hyperkalemia induced T wave oversensing leading to loss of biventricular pacing and inappropriate ICD shocks.

Authors:  Ashok K Koul; Seth Keller; Jude F Clancy; Rachel Lampert; William P Batsford; Lynda E Rosenfeld
Journal:  Pacing Clin Electrophysiol       Date:  2004-05       Impact factor: 1.976

10.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Authors:  Alan Kadish; Alan Dyer; James P Daubert; Rebecca Quigg; N A Mark Estes; Kelley P Anderson; Hugh Calkins; David Hoch; Jeffrey Goldberger; Alaa Shalaby; William E Sanders; Andi Schaechter; Joseph H Levine
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.